AsOf

Recorded or changed on this day 2026-11-08

2,151–2,200 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 767,355,259 shares
Amgen shares outstanding: 767,355,259 shares, claim clm_6365725354C1 · ended · superseded by clm_ACDCA67E4AE4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 5,877,000,000 United States dollar
Amgen total equity: 5,877,000,000 United States dollar, claim clm_636768003464 · ended · superseded by clm_4988A9F733D5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 80,331,000,000 United States dollar
Amgen total assets: 80,331,000,000 United States dollar, claim clm_643B856508E4 · ended · superseded by clm_718943D64327 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 21,662,000,000 United States dollar
Amgen revenue: 21,662,000,000 United States dollar, claim clm_6460A66923A8 · ended · superseded by clm_33F31087C483 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 735,399,128 shares
Amgen shares outstanding: 735,399,128 shares, claim clm_64EE6A24BD4B · ended · superseded by clm_4DCBBE171CD3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 7,989,000,000 United States dollar
Amgen cash and equivalents: 7,989,000,000 United States dollar, claim clm_65015952E899 · ended · superseded by clm_F90753F8299C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,321,000,000 United States dollar
Amgen quarterly operating income: 1,321,000,000 United States dollar, claim clm_6609F02715B5 · ended · superseded by clm_A972FFF57CA8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,266,000,000 United States dollar
Amgen cash and equivalents: 2,266,000,000 United States dollar, claim clm_66B8EB012276 · ended · superseded by clm_8100A4FAF341 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 7,264,000,000 United States dollar
Amgen net income: 7,264,000,000 United States dollar, claim clm_673D61CD1F43 · ended · superseded by clm_BF2E5D6BD634 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 25,614,000,000 United States dollar
Amgen total equity: 25,614,000,000 United States dollar, claim clm_67DA709539BB · ended · superseded by clm_1B908EDA7C06 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · cash and equivalents · 13,190,000,000 United States dollar
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Amgen · X · Amgen
Amgen X: Amgen, claim clm_683636E2586E · new claim · 1 source · conf 0.60
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,129,000,000 United States dollar
Amgen quarterly operating income: 2,129,000,000 United States dollar, claim clm_687CDFCB7970 · ended · superseded by clm_CDC5FFCBE990 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 916,000,000 United States dollar
Amgen total equity: 916,000,000 United States dollar, claim clm_68A37D10302E · ended · superseded by clm_4BB765E7F1FC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 534,326,594 shares
Amgen shares outstanding: 534,326,594 shares, claim clm_69A1D6DBF618 · ended · superseded by clm_613418445F18 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,646,000,000 United States dollar
Amgen quarterly net income: 1,646,000,000 United States dollar, claim clm_6B1B858C967C · ended · superseded by clm_C8266FA25464 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 42,714,000,000 United States dollar
Amgen total assets: 42,714,000,000 United States dollar, claim clm_6C5A646418EB · ended · superseded by clm_C21B53A4E862 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,946,000,000 United States dollar
Amgen cash and equivalents: 6,946,000,000 United States dollar, claim clm_6D27166168D8 · ended · superseded by clm_1146A0E24CD4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 958,474,477 shares
Amgen shares outstanding: 958,474,477 shares, claim clm_6D323A1AD7AE · ended · superseded by clm_5E708B99CEDB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 8,217,000,000 United States dollar
Amgen total equity: 8,217,000,000 United States dollar, claim clm_6DC2B1698886 · ended · superseded by clm_BF8A71350904 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,170,000,000 United States dollar
Amgen quarterly net income: 1,170,000,000 United States dollar, claim clm_6E8F27E2EA0D · ended · superseded by clm_EBFAA5FF45E6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 777,707,877 shares
Amgen shares outstanding: 777,707,877 shares, claim clm_70560450A8A4 · ended · superseded by clm_540E74003993 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 637,219,244 shares
Amgen shares outstanding: 637,219,244 shares, claim clm_709BAAA1A0C7 · ended · superseded by clm_CE1D1BBB65EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 535,178,027 shares
Amgen shares outstanding: 535,178,027 shares, claim clm_70B9E417B378 · ended · superseded by clm_5D00EFAD6C71 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 23,170,000,000 United States dollar
Amgen total equity: 23,170,000,000 United States dollar, claim clm_70DC668489EA · ended · superseded by clm_40DAD67567CD · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · net income · 7,711,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 5,022,000,000 United States dollar
Amgen total equity: 5,022,000,000 United States dollar, claim clm_713550ADBC39 · ended · superseded by clm_AC23A926EFAF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 95,639,000,000 United States dollar
Amgen total assets: 95,639,000,000 United States dollar, claim clm_716046ECC37B · ended · superseded by clm_8D59A495A2F7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 79,954,000,000 United States dollar
Amgen total assets: 79,954,000,000 United States dollar, claim clm_718943D64327 · ended · superseded by clm_3E0AC172DD20 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 957,938,383 shares
Amgen shares outstanding: 957,938,383 shares, claim clm_718FD5DF2CAF · ended · superseded by clm_6D323A1AD7AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 10,944,000,000 United States dollar
Amgen cash and equivalents: 10,944,000,000 United States dollar, claim clm_71DDBB020158 · ended · superseded by clm_85A3377148F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,021,000,000 United States dollar
Amgen quarterly net income: 2,021,000,000 United States dollar, claim clm_733FEFB5E7FA · ended · superseded by clm_6B1B858C967C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,554,000,000 United States dollar
Amgen quarterly revenue: 5,554,000,000 United States dollar, claim clm_756E88917872 · ended · superseded by clm_AAF52E028DB6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 25,325,000,000 United States dollar
Amgen total equity: 25,325,000,000 United States dollar, claim clm_7580FDD62A85 · ended · superseded by clm_E3E3E7359787 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 57,073,000,000 United States dollar
Amgen total assets: 57,073,000,000 United States dollar, claim clm_76443A277A6C · ended · superseded by clm_A0287B4C76BE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 26,506,000,000 United States dollar
Amgen total equity: 26,506,000,000 United States dollar, claim clm_771831E45D09 · ended · superseded by clm_C5ED4B615A7E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 3,683,000,000 United States dollar
Amgen net income: 3,683,000,000 United States dollar, claim clm_77675AD86D11 · ended · superseded by clm_84C2CE669D18 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 25,979,000,000 United States dollar
Amgen revenue: 25,979,000,000 United States dollar, claim clm_77883252E88F · ended · superseded by clm_142A6C7A0E55 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,706,000,000 United States dollar
Amgen quarterly revenue: 6,706,000,000 United States dollar, claim clm_77995E036FCF · ended · superseded by clm_7ED75B6E7D04 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,891,000,000 United States dollar
Amgen cash and equivalents: 3,891,000,000 United States dollar, claim clm_787BD95A43CF · ended · superseded by clm_6D27166168D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,660,000,000 United States dollar
Amgen quarterly operating income: 2,660,000,000 United States dollar, claim clm_78C2CEAEC57D · ended · superseded by clm_87A3CD3A03BE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 4,605,000,000 United States dollar
Amgen net income: 4,605,000,000 United States dollar, claim clm_78DDCE0217FE · ended · superseded by clm_A36EA59B9520 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · registrant name · AMGEN INC
Amgen registrant name: AMGEN INC, claim clm_7924DEE14027 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 753,356,209 shares
Amgen shares outstanding: 753,356,209 shares, claim clm_7946AE508D58 · ended · superseded by clm_FFC4D3147C5E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 6,939,000,000 United States dollar
Amgen net income: 6,939,000,000 United States dollar, claim clm_797A8E0010E4 · ended · superseded by clm_A5BF59D89483 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,884,000,000 United States dollar
Amgen quarterly net income: 1,884,000,000 United States dollar, claim clm_79D0F6379AE0 · ended · superseded by clm_14453E457A66 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,530,000,000 United States dollar
Amgen cash and equivalents: 2,530,000,000 United States dollar, claim clm_7A1F93F832FE · ended · superseded by clm_2E4B5E4DFAE5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,301,000,000 United States dollar
Amgen cash and equivalents: 9,301,000,000 United States dollar, claim clm_7A6976D86AF0 · ended · superseded by clm_635D97E40729 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,951,000,000 United States dollar
Amgen cash and equivalents: 2,951,000,000 United States dollar, claim clm_7B2497997F4E · ended · superseded by clm_BBB0BE58C057 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,317,000,000 United States dollar
Amgen quarterly net income: 1,317,000,000 United States dollar, claim clm_7BC494395A3F · ended · superseded by clm_35CDE21699AB · 1 source (1 primary) · conf 0.95

What the statuses mean